THEUNSEEN Overview
- Year Founded
-
2013

- Status
-
Private
- Employees
-
11

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.06M
- Investors
-
2
THEUNSEEN General Information
Description
Operator of chemical innovation licensing studio intended to captivate complicated science into exquisite couture, luxury products, and opulent materials. The company's studio creates color, translating data into simple, intuitive, and impactful concepts that improve lives by imagining, designing, developing, and launching beautifully designed products, infused with color-change chemistry rooted in material science and data, enabling customers to visualize data, create intelligent materials and fashion products to communicate and engage with previously invisible data that is not easily expressed or understood.
Contact Information
Website
seetheunseen.co.ukCorporate Office
- Unit B, Dalston Works 3 Martel Place
- Dalston
- London E8 2FQ
- England, United Kingdom
Corporate Office
- Unit B, Dalston Works 3 Martel Place
- Dalston
- London E8 2FQ
- England, United Kingdom
THEUNSEEN Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 08-Apr-2022 | $1.06M | Completed | Generating Revenue | ||
4. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
3. Early Stage VC | 15-May-2017 | Completed | Generating Revenue | |||
2. Early Stage VC | 27-Mar-2015 | $391K | $432K | Completed | Generating Revenue | |
1. Early Stage VC | 27-Jan-2014 | $41.2K | $41.2K | Completed | Startup |
THEUNSEEN Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 28,888 | $0.000013 | $11.81 | $11.81 | 1x | $11.81 | 13.2% | |
Ordinary | 11,100 | $0.000013 | $2.96 | $2.96 | 1x | $2.96 | 5.07% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
THEUNSEEN Patents
THEUNSEEN Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-2616956-A | Antimicrobial indicator composition | Pending | 28-Jan-2022 | ||
GB-202201166-D0 | Antimicrobial indicator composition | Inactive | 28-Jan-2022 | ||
GB-202301326-D0 | Antimicrobial indicator composition | Pending | 28-Jan-2022 | ||
GB-201918142-D0 | Cosmetic composition | Inactive | 10-Dec-2019 | ||
GB-2589883-A | Cosmetic composition | Inactive | 10-Dec-2019 | A61K8/19 |
THEUNSEEN Signals
THEUNSEEN Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Innovate UK | Accelerator/Incubator | |||
True. | PE/Buyout | Minority |
THEUNSEEN FAQs
-
When was THEUNSEEN founded?
THEUNSEEN was founded in 2013.
-
Where is THEUNSEEN headquartered?
THEUNSEEN is headquartered in London, United Kingdom.
-
What is the size of THEUNSEEN?
THEUNSEEN has 11 total employees.
-
What industry is THEUNSEEN in?
THEUNSEEN’s primary industry is Personal Products.
-
Is THEUNSEEN a private or public company?
THEUNSEEN is a Private company.
-
What is the current valuation of THEUNSEEN?
The current valuation of THEUNSEEN is
. -
What is THEUNSEEN’s current revenue?
The current revenue for THEUNSEEN is
. -
How much funding has THEUNSEEN raised over time?
THEUNSEEN has raised $1.76M.
-
Who are THEUNSEEN’s investors?
Innovate UK and True. have invested in THEUNSEEN.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »